BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12546745)

  • 1. [Application of blood purification technique in artificial liver support therapy].
    Guo LM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):43. PubMed ID: 12546745
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apheresis treatment for fulminant hepatitis].
    Tateishi Y; Hirasawa H; Nitta M
    Nihon Rinsho; 2004 May; 62 Suppl 5():462-6. PubMed ID: 15197964
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful management of germanium poisoning-induced multiple organ dysfunctions by combined blood purification therapy.
    Wang L; Zheng C; Zhao D
    Curr Med Res Opin; 2020 Apr; 36(4):687-691. PubMed ID: 31951756
    [No Abstract]   [Full Text] [Related]  

  • 4. [Model selection and curative effect judgment criteria for artificial liver in the treatment of liver failure].
    Zhou L; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2022 Feb; 30(2):127-130. PubMed ID: 35359063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver support technology--an update.
    Rozga J
    Xenotransplantation; 2006 Sep; 13(5):380-9. PubMed ID: 16925661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Support for the acutely failing liver: a comprehensive review of historic and contemporary strategies.
    Barshes NR; Gay AN; Williams B; Patel AJ; Awad SS
    J Am Coll Surg; 2005 Sep; 201(3):458-76. PubMed ID: 16125082
    [No Abstract]   [Full Text] [Related]  

  • 7. Artificial liver support system using large buffer volumes removes significant glutamine and is an ideal bridge to liver transplantation.
    Inoue K; Kourin A; Watanabe T; Yamada M; Yoshiba M
    Transplant Proc; 2009; 41(1):259-61. PubMed ID: 19249529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasmapheresis: intermediate artificial liver].
    Wang YJ
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jan; 11(1):41. PubMed ID: 12546743
    [No Abstract]   [Full Text] [Related]  

  • 9. Artificial in vivo biofiltration: slow continuous intravenous plasmafiltration (SCIP) and artificial organ support.
    Handley HH; Ronco F; Gorsuch R; Peters H; Cooper TG; Levin NW
    Int J Artif Organs; 2004 Mar; 27(3):186-94. PubMed ID: 15112884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the prognosis of severe hepatitis treated with molecular adsorbent recycling system (MARS) using MELD score].
    Sun LH; Zhang YX; Xiao L; Lu XB
    Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):632, 635. PubMed ID: 16093004
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of serum leptin clearance with different blood purification].
    Lou TQ; You YP; Chen ZJ; Shi CG; Liu X; Tang H
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Dec; 15(12):742-4. PubMed ID: 14659060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failure.
    Yokoi T; Oda S; Shiga H; Matsuda K; Sadahiro T; Nakamura M; Hirasawa H
    Transfus Apher Sci; 2009 Feb; 40(1):61-70. PubMed ID: 19117803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial and bioartificial liver support.
    McKenzie TJ; Lillegard JB; Nyberg SL
    Semin Liver Dis; 2008 May; 28(2):210-7. PubMed ID: 18452120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial hepatic support. Where are we now?
    Davenport A
    Blood Purif; 2001; 19(1):1-3. PubMed ID: 11190653
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system.
    Tan HK; Yang WS; Chow P; Lui HF; Choong HL; Wong KS
    Artif Organs; 2007 Mar; 31(3):193-9. PubMed ID: 17343694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case report of pediatric fulminant hepatitis treated with plasma diafiltration.
    Nakae H; Igarashi T; Tajimi K; Noguchi A; Takahashi I; Tsuchida S; Takahashi T; Asanuma Y
    Ther Apher Dial; 2008 Aug; 12(4):329-32. PubMed ID: 18789121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quo vadis haemapheresis. Current developments in haemapheresis.
    Borberg H
    Transfus Apher Sci; 2006 Feb; 34(1):51-73. PubMed ID: 16412691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cascade filtration in Refsum's disease.
    Siegmund JB; Meier H; Hoppmann I; Gutsche HU
    Nephrol Dial Transplant; 1995; 10(1):117-9. PubMed ID: 7536903
    [No Abstract]   [Full Text] [Related]  

  • 19. Artificial liver support system in China: a review over the last 30 years.
    Li LJ; Zhang YM; Liu XL; Du WB; Huang JR; Yang Q; Xu XW; Chen YM
    Ther Apher Dial; 2006 Apr; 10(2):160-7. PubMed ID: 16684218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New devices in liver replacement therapy].
    Rifai K; Bahr MJ; Schneider A; Ott M; Manns MP
    Med Klin (Munich); 2003 Dec; 98(12):750-3. PubMed ID: 14685676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.